Medical Care Technologies Inc. (OTC PINK:MDCE) Nears Completion of AI-Powered App Targeting the $4.5 Billion Global Nutrition & Recipe Market

October 28, 2025 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that its first AI-driven mobile application, [App Name Pending Trademark], has entered its final development phase. The app uses image recognition to create recipes and also analyzes nutrition data directly from food photos. MDCE plans to deploy the app in 175 countries and in over 30 languages. According to industry research, the global diet & nutrition apps market is valued at...

Read more

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

October 28, 2025 9:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that the method of use patent (U.S. Patent No. 7,538,116) for EXXUATM (gepirone) extended-release tablets ("EXXUA") has been extended through September 2, 2030 under 35 U.S.C. 156. The patent extension further...

Read more

Modular Medical Announces Ongoing Progress to Obtain CE Mark

October 28, 2025 8:30 AM

Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery, today announced that it is continuing to progress toward CE Mark certification under the European Union Medical Device Regulation ("EU MDR 2017/745"). As part of this process, the Company is pleased to announce the successful completion of its Stage 1 ISO 13485:2016 audit, conducted by BSI, its Notified Body and Registrar.The audit...

Read more

VSee Awarded US Department of Health & Human Services FedRAMP High ATO

October 28, 2025 8:20 AM

VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), announced it has received its Authority to Operate (ATO) at the FedRAMP High level from the U.S. Department of Health and Human Services (HHS). The authorization also allows other federal agencies to use VSee where FedRAMP High is required. The platform enables government partners to increase healthcare accessibility in remote locations and relieve medical surge events withenterprise-grade...

Read more

Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud

October 28, 2025 8:00 AM

Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace.SiteLink accelerates study startup and enables real-time document distribution, monitoring, and data exchange with study sites, addressing the critical digital divide in clinical trials. With only 30% of...

Read more

WellBridge Surgical Celebrates Dual Achievement: ACHC Accreditation and 2025 Best Places to Work Honor

October 28, 2025 8:00 AM

WellBridge Surgical ("WellBridge") is delighted to announce two major milestones that underscore its unwavering commitment to both clinical excellence and workplace culture:Accreditation by the Accreditation Commission for Health Care (ACHC) for its outpatient surgical facility - a hallmark of quality, safety and operational rigor.Named a winner of the 2025 Indiana Chamber of Commerce "Best Places to Work in Indiana" program, confirming that its...

Read more

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

October 28, 2025 7:45 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced that its wholly owned subsidiary, Nora Pharma Inc., has received approval from Health Canada, the Canadian equivalent to the FDA, for the commercialization of Domperidone, a prescription medication used to relieve nausea and vomiting and to enhance gastrointestinal motility.Domperidone...

Read more

CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies

October 28, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), an emerging leader in wellness innovation and nutraceutical advancement, proudly announces the official launch of its new Energy Boost and Diet & Weight-Loss Hemp-Free Gummies, both formulated with 100 mg vegan, plant-based ingredients. These new releases position CBDL at the intersection of two of the most explosive consumer categories in the global supplement market: energy enhancement and weight...

Read more

SEAL Analytical Launches New Website Featuring Bioz Badges, Applauds Seamless Integration and Service Excellence

October 28, 2025 4:00 AM

Bioz, Inc., a driving force behind AI citation insight platforms, is proud to announce the successful integration of Bioz Badges on SEAL Analytical's newly redesigned website. Known for their innovative wet chemistry automation solutions, including discrete analyzers, continuous flow analyzers, and automated BOD robotics, SEAL Analytical is now enhancing the researcher journey with real-time scientific validation, made possible through a...

Read more

Onco-Innovations Announces Closing of Private Placement

October 27, 2025 5:15 PM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce that it has closed its previously-announced (see news release dated October 14, 2025) non-brokered private placement (the "Private Placement"), issuing 1,428,570 units of the Company (the "Units") at a price of $1.40 per Unit, for aggregate gross proceeds of $2,000,000. Each Unit consists of one common share (each a...

Read more

UniDoc Closes Fully Subscribed LIFE Offering

October 27, 2025 5:00 PM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement LIFE offering (the "Offering") by issuing 10,000,000 units (each a "Unit") at a price of $0.15 per Unit for aggregate gross proceeds of $1,500,000.Each Unit consists of one common share in the capital of the Company and one transferrable common share purchase warrant (a...

Read more

The Assistance Fund Opens New Program for Immunoglobulin G4-Related Disease

October 27, 2025 12:00 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with immunoglobulin G4-related disease. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, health insurance premiums, and incidental...

Read more

SoftWriters Welcomes Jeff Hlozek as Chief Revenue Officer

October 27, 2025 11:15 AM

SoftWriters, the leading provider of pharmacy management software for long-term care (LTC) pharmacies, is pleased to announce the appointment of Jeff Hlozek as its Chief Revenue Officer (CRO). In this newly created role, Hlozek will lead SoftWriters' Sales and Marketing organization and drive strategic growth and alignment across the company's product suite.With more than 25 years of leadership experience spanning healthcare technology,...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as an Official Google Play Developer

October 27, 2025 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) has been approved as an official developer on the Google Play Store, allowing the company to deploy its AI-powered mobile applications across Android devices around the world. "This approval opens the door for us to bring our technology to millions of Android users around the world," said Marshall Perkins, CEO. "We look forward to launching our upcoming app and expanding MDCE's reach through the...

Read more

Apex Health Names Ruth Krystopolski as Executive Vice President and Chief Operating Officer

October 27, 2025 9:00 AM

Apex Health, a tech-enabled management services organization (MSO) that enhances the enterprise value of health systems, today announced the appointment of Ruth Krystopolski, MBA, as Executive Vice President and Chief Operating Officer. In this new role, Krystopolski will oversee enterprise operations and execution across Apex's growing health system partnerships.Krystopolski brings more than 30 years of executive leadership experience across...

Read more

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

October 27, 2025 8:45 AM

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting on Monday, October 27th, at 03:00pm at the PODD 2025 Conference in Boston, MA.Event Information:EventNanoViricides Presentation at the PODD 2025, Boston, MATrack5ADateMonday, October 27, 2025Time03:00 pmLocationSt. George, ABC, at Westin...

Read more

Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

October 27, 2025 8:30 AM

"STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition and Innoventure Dynamic LLC of India announced on October 23, 2025, a dynamic joint venture, creating Stemtech HealthSciences India Pvt Ltd, a subsidiary of Stemtech Corporation, a Nevada company (OTCQB:STEK).The India MarketStemtech Corporation Chairman & CEO, Charles S. Arnold, states "STEMTECH HEALTHSCIENCES INDIA PVT LTD (SHIPL) is dedicated to bringing...

Read more

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences

October 27, 2025 7:35 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced new data from two studies of icotrokinra, a first-in-class investigational targeted oral peptide that precisely blocks the IL-23 receptor, presented at two recent medical conferences.Week 28 data from the Phase 2b ANTHEM-UC study of icotrokinra will be presented at the 2025 American College of Gastroenterology Annual Scientific Meeting (ACG), demonstrating sustained...

Read more

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

October 27, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2025 ended September 30, 2025, after the market closes on Thursday, November 6, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To access the conference call, dial toll-free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference.The call can...

Read more

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

October 27, 2025 2:50 AM

Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced that the Company has received a payment of US$ 25 m from Bristol Myers Squibb (NYSE: BMY) for scientific progress achieved within their strategic neuroscience partnership. The payment will advance further research and the partners' joint pipeline of programs aimed at tackling neurogenerative diseases.Launched in...

Read more